Shengwei Tao

机构：University of Science and Technology of China, Anhui Provincial Hospital

发表论文 8 篇 · 总被引 105 次 · h-index 5

代表论文

• Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition (2023 · Frontiers in Immunology · 被引 40)
• Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation (2025 · Nature Communications · 被引 32)
• Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response (2025 · Journal of Hepatology · 被引 13)
• VCP downstream metabolite glycerol-3-phosphate (G3P) inhibits CD8+T cells function in the HCC microenvironment (2025 · Signal Transduction and Targeted Therapy · 被引 11)
• Intracerebral opportunistic infections caused by immunosuppressants after orthotopic liver transplantation: Report of two cases and literature review (2022 · Frontiers in Immunology · 被引 6)
• IFRD1 orchestrates hepatocyte metabolism and macrophage interactions to facilitate liver regeneration (2026 · Journal of Hepatology · 被引 3)